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Purpose: To investigate the efficacy of lacrimal silicone intubation for the management of epiphora in 
patients who have previously undergone anatomically successful dacryocystorhinostomy (DCR).
Methods: The authors recruited 13 patients (4 male, 9 female) who had persistent epiphora after an 
anatomically successful primary external DCR and conducted lacrimal silicone intubation through the 
dacryocystorhinostomy site. 
Results: Mean patient age was 54.2 years (range 42-80) and mean follow-up was 13.8 months (range 
6-30). Epiphora was resolved in all 13 patients following silicone intubation. Spontaneous tube extrusion 
occurred in three patients, but a new one was easily reintubated. 
Conclusions: Lacrimal silicone intubation is a simple safe and effective procedure for patients with epiphora 
even after anatomically successful DCR. 
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External dacryocystorhinostomy (DCR) is an effective 
surgical treatment for nasolacrimal duct obstruction, and 
consistently yields a success rate greater than 90%.
1,2 
However, epiphora might remain in some patients even after 
anatomically successful DCR.
3,4 Moreover, as far as we are 
aware, no effective means of treating these functional failures 
has been reported.
Our interest in this topic arose when one of our patients 
underwent primary external DCR and silicone intubation, 
which successfully resolved epiphora postoperatively, but 
which recurred after the silicone tube was removed at 4 
months postoperatively, as had been planned. The authors 
relocated the silicone tube in this patient, which again 
resolved the epiphora. This experience suggested that silicone 
tubes intubated into DCR sites might play a significant role 
in lacrimal drainage, even when a patent bypass route has 
been established by DCR. The authors therefore considered 
that silicone intubation might resolve epiphora in cases of 
anatomically patent but functionally failed DCR. Thus, we 
began to more confidently utilize this technique of silicone 
intubation into DCR sites to address persistent or recurrent 
epiphora after successful DCR. This study was conducted to 
evaluate the efficacy of this procedure for the correction of 
epiphora in patients that have received an anatomically patent 
but functionally failed DCR.
The Subject and Methods
Among patients who received primary external DCR with 
silicone intubation and experienced epiphora resolution, 10 
patients with epiphora recurrence immediately after silicone 
tube removal were included in this study.  We also included 
3 patients who had received primary external DCR without 
silicone intubation and had persistent epiphora despite an 
anatomically patent bypass route. All of these patients had 
complete nasolacrimal duct (NLD) obstruction on irrigation 
before primary external DCR and had no obvious punctal or NJ Kim, et al. LACRIMAL INTUBATION FOR FUNCTIONALLY FAILED DCR
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Case Sex Age Side Diagnosis
Primary silicone 
intubation during 
primary DCR
Epiphora
Interval between 
DCR and silicone
intubation (Mo.) 
Follow up
duration 
(Mo.)
Results of
 epiphora
Tube
 extrusion
1F 5 7 R P A N D O + Recurrence* 91 r e s o l v e d -
2F 6 0 L P A N D O + Recurrence* 5 24 resolved -
3F 8 0 L P A N D O + Recurrence* 5 11 resolved -
4F 4 2 L
PANDO with
chronic 
dacryocystitis
+ Recurrence* 46 r e s o l v e d -
5F 4 8 L P A N D O + Recurrence* 6 18 resolved +
6F 6 2 R P A N D O + Recurrence* 73 r e s o l v e d -
7M 4 3L P A N D O + Recurrence* 98 r e s o l v e d +
8M 4 3R P A N D O - Persistence
† 68 r e s o l v e d +
9F 5 2 L P A N D O + Recurrence* 7 14 resolved -
10 F 43 L PANDO - Persistence
† 21 r e s o l v e d -
11 F 53 L
PANDO with 
chronic 
dacryocystitis
+ Recurrence* 11 5 resolved -
12 M 47 R Partial NDO - Persistence
† 19 r e s o l v e d -
13 F 77 R PANDO + Recurrence*  4 19 resolved -
PANDO: primary acquired nasolacrimal duct obstruction.
Recurrence
*: recurrence of epiphora immediately after planned silicone tube removal after DCR.
Persistence
†: persistence of epiphora since primary DCR, where no silicone tube was placed.
Table 1. The clinical characteristics and outcomes of the 13 patients who underwent secondary silicone intubation because of 
persistent or recurrent epiphora after anatomically successful DCR.
eyelid abnormality. For these 13 patients, silicone intubation 
was conducted to manage epiphora during the study period 
from June 2003 to August 2005. All surgeries including 
primary external DCR and secondary silicone intubation were 
preformed by one of the authors (SIK) using a standard 
technique at the Seoul National University Hospital.
Before the procedure, tests were performed ensuring that 
all patients had an increased tear lake, appropriately 
positioned lower punctum, fluorescein dye retention on the 
dye disappearance test, and completely patent lacrimal 
irrigation. After informed consent had been obtained, 
lacrimal silicone intubation was conducted through the 
dacryocystorhinostomy site at an outpatient clinic. The 
procedure commenced with nasal packing using a 1:1 mixture 
of epinephrine (1 mg/ml) and 4% lidocaine. A bicanalicular 
silicone tube was introduced into the DCR site through the 
upper and lower punctum and drawn out from the nasal 
cavity with a straight hemostat under direct visualisation. The 
ends of the tube were tied together with 6-0 black silk at a 
point where the knot could seat deeply in the nasal cavity, 
and then left free in the nasal cavity.
Patients were followed up at one week, one month, and 
then 3 monthly after silicone intubation. On every visit, 
patients were asked about their epiphora symptom, and 
examined for tear meniscus height and silicone tube status. 
Postoperative assessments of epiphora were based on the 
subjective report and the tear lake examination. No uniform 
dye disappearance test was conducted postoperatively.
We performed a retrospective analysis of 13 patients who 
underwent secondary silicone intubation during the study 
period after successful DCR. Charts were reviewed for age, 
sex, follow-up duration, resolution of epiphora, and 
complications. The study was approved by the institutional 
review board.
Results
The results of secondary silicone intubation in the 13 study 
subjects are summarized in Table 1. Mean patient age was 
54.2 years (range 42-80), mean follow-up was 13.8 months 
(range 6-30), and the mean interval between primary DCR 
and silicone intubation was 5.47 months (range 2-10). Of 
these 13 patients, 10 had received primary external DCR with 
silicone intubation and 3 had received primary external DCR 
without silicone intubation.
All 13 patients reported complete resolution of epiphora 
and presented a normal tear lake by slit lamp biomicroscopic 
examination after silicone intubation (Fig. 1, 2). Spontaneous 
tube extrusion occurred in three patients, and they 
complained recurrent epiphora right after its extrusion. New 
tubes were easily reintubated. Silicone tube-related 
complications, such as granuloma, canalicular or punctal 
slitting were absent postoperatively. As far as there is no 
tube-related complication, tubes will be maintained in situ. 
Discussion
If complete anatomic obstruction is the cause of DCR 
failure, a secondary bypassing surgical procedure is 
necessary, and may be successful. Kor J Ophthalmol Vol.21, No.2, 2007
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Fig. 1. Result of Fluorescein dye disappearance test before 
silicone intubation (A: immediately after dye instillation, B: 
five minutes after dye instillation) This patient complained of 
epiphora recurrence in the left eye after the planned removal of
the silicone tube following anatomically patent DCR. Note that
fluorescein dye remained in left eye on dye disappearance test
(Bottom right, arrow).
Fig. 2. Result of Fluorescein dye disappearance test of the 
same patient 1 month after silicone intubation in the left eye 
(A: immediately after dye instillation, B: five minutes after 
dye instillation) Note the symmetric disappearance of 
fluorescein dye from both eyes (Bottom right, arrow). 
However, in cases of failure caused by a nonfunctioning 
but patent DCR with no obvious punctal or eyelid 
abnormality, the situation is less clear. Amin et al,
4 using 
intubation dacryocystography after DCR, found no anatomic 
or physiologic abnormality in 58% of patients that experienced 
postoperative epiphora recurrence. Furthermore, there is no 
known effective treatment for epiphora in cases with an 
anatomically patent but functionally failed DCR.
This study demonstrates that silicone intubation can result 
in the resolution of epiphora in cases of anatomically patent 
but functionally failed DCR. This approach was easily 
performed and proved successful in all patients. Epiphora was 
completely resolved in all patients, without any significant 
complication.
Slow dye disappearance on the fluorescein dye 
disappearance (FDD) test, which was observed before 
secondary silicone intubation in all cases of the present study, 
may indicate lacrimal pump dysfunction, and thus, affected 
patients would benefit from a procedure to augment lacrimal 
pump function. Therefore, we assume that lacrimal silicone 
intubation, conducted in the present study, must have affected 
the lacrimal pump.
One possible explanation why epiphora was resolved after 
silicone intubation is that bicanalicular silicone intubation can 
control punctal position by supporting it, and thus help both 
upper and lower puncta oppose well during the closure phase 
of blinking, and thus enhance lacrimal pump function. 
Another possible explanation is provided by the capillary 
phenomenon. Small canaliculi may act as capillary tubes, and 
capillarity tends to occur more strongly in narrow bore tubes 
than in wider ones. Therefore, because silicone intubation 
causes the canalicular lumen to narrow, it increases 
capillarity, and thus enhances lacrimal tear drainage. 
However, despite all these assumption, the exact mechanism 
of epiphora resolution is not clear. 
We are also aware of the limitations of the present study. 
For example, objective postoperative lacrimal drainage 
assessment using the fluorescein dye disappearance test was 
not performed in all patients. Although these represent 
weaknesses in our study method, the fact that all patients 
improved following intervention strongly indicates that the 
described operative technique of silicone intubation is 
beneficial. We based our assessment on patients' clinical 
symptoms, and Schirmer testing and tear break-up time were 
not quantified. However, all patients presented with a 
complaint of tearing, were positive for dye retention on dye 
disappearance test, and were patent to nasolacrimal irrigation. 
The mean follow-up time of this study (13.8 months) is not 
long enough to fully evaluate long term complications by 
leaving the tubes in-situ indefinitely. Despite the possibility 
of silicone tube-related long term complications, it is still 
more meaningful to have silicone tube intubation and not to 
suffer epiphora, at least, before long-term complications may 
develop, than just to do nothing about the symptom for fear 
of complication and suffer epiphora, because there is no other 
established management in such cases. Moreover, it might 
have been beneficial, if we could assess our patients not only 
in a prospective fashion but if we had also looked at the nasal 
ostium and performed preoperative Jones 1 and 2 testing and 
postoperative Jones 1 testing, using nasal endoscopy, in all 
patients. However, as reported by Conway,
5 we are in the 
mainstream of current ASOPRS members and do not 
routinely perform such testing.
Nevertheless, given the above limitations, we believe that 
the results obtained suggest an approach to epiphora 
management after anatomically successful DCR, and 
conclude that lacrimal silicone intubation is a simple, safe 
and effective procedure for patients with epiphora after 
anatomically successful DCR. NJ Kim, et al. LACRIMAL INTUBATION FOR FUNCTIONALLY FAILED DCR
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